Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Fukuyama type muscular dystrophy


Other Names for this Disease
  • FCMD
  • Muscular dystrophy, congenital progressive, with mental retardation
  • Muscular dystrophy, congenital, with central nervous system involvement
  • Muscular dystrophy, congenital, Fukuyama type
  • Cerebromuscular dystrophy, Fukuyama type
Related Diseases
  • Congenital disorder of glycosylation with developmental anomaly
  • Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies
  • Congenital muscular dystrophy
  • Congenital muscular dystrophy due to dystroglycanopathy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

News & Events


News


NCATS Co-Sponsored Conferences

  • American Society of Gene & Cell Therapy (ASGCT) 19th Annual Meeting, Wednesday, May 04, 2016 - Saturday, May 07, 2016
    Location: Washington, DC
    Description: Save the date and plan to head to Washington, DC on May 4-7, 2016, for the premiere gene and cell therapy conference in the world. Taking place at the Marriott Wardman Park Hotel, the ASGCT 19th Annual Meeting will feature ground breaking clinical trial results, cutting edge technology advancements, social networking events, and much more. Join over 1,900 of the worlds top gene and cell therapy professionals for four full days of educational offerings including plenary lectures given by Dr. David R. Liu and 2015 Japan Prize recipients, Dr. Alain Fischer, and Dr. Theodore Friedmann.

  • Congenital Muscular Dystrophy: From Clinical Pathology to Underlying Scientific Mechanisms, Exploring the Role of the Myomatrix, Sunday, April 22, 2012 - Tuesday, April 24, 2012
    Location: University of Nevada School of Medicine, Center for Molecular Medicine, Reno, NV
    Description: The goals of the conference are to: 1) Establish the current state of knowledge in different myomatrix research areas germane to the CMDs and to dystrophic pathology, 2) Explore novel mechanisms, intersections and crosstalk of relevant mechanisms and perform comparative analysis across disease models, 3) Design effective strategies and platforms to pursue treatment development for key aspects of CMD clinical pathology to drive future translational opportunities

Other Names for this Disease
  • FCMD
  • Muscular dystrophy, congenital progressive, with mental retardation
  • Muscular dystrophy, congenital, with central nervous system involvement
  • Muscular dystrophy, congenital, Fukuyama type
  • Cerebromuscular dystrophy, Fukuyama type
Related Diseases
  • Congenital disorder of glycosylation with developmental anomaly
  • Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies
  • Congenital muscular dystrophy
  • Congenital muscular dystrophy due to dystroglycanopathy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.